Latest publications

• Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases

  Hilbers, Marie-Luise; Dimitriou, Florentia; Lau, Peter; Bhave, Prachi; McArthur, Grant A; Zimmer, Lisa; Kudura, Ken; Gérard, Camille L; Levesque, Mitchell P; Michielin, Olivier; Dummer, Reinhard; Cheng, Phil F; Mangana, Joanna

  2021-08-25
• Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma

  Owen, C N; Bai, X; Quah, T; Lo, S N; Allayous, C; Callaghan, S; Martínez-Vila, C; Wallace, R; Bhave, P; Reijers, I L M; Thompson, N; Vanella, V; Gerard, C L; Aspeslagh, S; Labianca, A; Khattak, A; Mandala, M; Xu, W; Neyns, B; Michielin, Olivier; Blank, C U; Welsh, S J; Haydon, A; Sandhu, S; Mangana, J; McQuade, J L; Ascierto, P A; Zimmer, L; Johnson, D B; Arance, A; Lorigan, P; Lebbé, C; Carlino, M S; Sullivan, R J; Long, G V; Menzies, A M

  2021-03-30
• Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response

  Dimitriou, Florentia; Zaremba, Anne; Allayous, Clara; Kähler, Katharina C; Gerard, Camille L; Festino, Lucia; Schäfer, Sarah; Toussaint, Frédéric; Heinzerling, Lucie; Hassel, Jessica C; Ascierto, Paolo A; Michielin, Olivier; Hauschild, Axel; Lebbe, Céleste; Livingstone, Elisabeth; Ramelyte, Egle; Cheng, Phil F; Dummer, Reinhard; Mangana, Joanna

  2021-04-03
• Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors

  Arangalage, Dimitri; Degrauwe, Nils; Michielin, Olivier; Monney, Pierre; Özdemir, Berna C

  2021-08-18
• Integrating radiomics into holomics for personalised oncology : from algorithms to bedside

  Gatta, Roberto; Depeursinge, Adrien; Ratib, Osman; Michielin, Olivier; Leimgruber, Antoine

  2020-02-07